Here's What Analysts Think of Allstate (ALL)

Allstate stock is trading -6.81% below its average target price of $149.77 after dropping -1.2% during today's morning session. Analysts are giving the large-cap Property & Casualty Insurance company an average rating of buy and target prices ranging from $100 to $188 per share.

The stock has a very low short interest at 1.2%, and a short ratio of 2.16. The company's insiders own 0.64% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 81.2% of Allstate's shares being owned by this investor type.

Institutions Invested in Allstate

Holder Shares Date Reported Percentage Value
Vanguard Group, Inc. (The) 25,700,343 2022-09-29 10% $3,586,739,806
Blackrock Inc. 21,995,212 2022-09-29 8% $3,069,651,733
State Street Corporation 12,363,707 2022-09-29 5% $1,725,478,918
Geode Capital Management, LLC 5,768,626 2022-09-29 2% $805,069,430
Invesco Ltd. 5,759,969 2022-09-29 2% $803,861,259
Charles Schwab Investment Management, Inc. 5,465,125 2022-09-29 2% $762,712,831
Barrow, Hanley Mewhinney & Strauss, LLC 5,028,442 2022-09-29 2% $701,769,353
American Century Companies, Inc. 4,854,350 2022-09-29 2% $677,473,074
Northern Trust Corporation 3,752,983 2022-09-29 1% $523,766,298
Deutsche Bank Aktiengesellschaft 3,416,362 2022-09-29 1% $476,787,472

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Allstate.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.